GemVax Bolsters Biotech Interests Through NovaHep Acquisition
This article was originally published in PharmAsia News
Executive Summary
GemVax Technology, an affiliate of South Korean group GemVax & KAEL, has signed a contract to acquire a controlling stake in small Swedish biotech firm NovaHep in an effort to diversify its business.